RxSight, Inc. reported third quarter 2025 financial results today, including a 14% year-over-year revenue decline and narrowed full-year guidance
https://finviz.com/quote.ashx?t=RXST&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.